Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSA | P10619 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22824211 | 0.83 | CTSA (0.37) | CTSAACHEALDH1A1KDM4EPOLB | |
| SCHEMBL11884745 | 0.79 | TSHR (0.42) | CTSAACHEALDH1A1KDM4EPOLB | |
| SCHEMBL22921227 | 0.78 | — | — | |
| SCHEMBL21764561 | 0.77 | TSHR (0.39) | CTSAACHEALDH1A1KDM4EPOLB | |
| SCHEMBL11152845 | 0.75 | CTSA (0.33) | CTSAACHE | |
| SCHEMBL19348752 | 0.75 | — | — | |
| SCHEMBL8399409 | 0.75 | — | — | |
| SCHEMBL19837949 | 0.74 | CTSA (0.39) | CTSAACHEALDH1A1KDM4EPOLB | |
| SCHEMBL19837950 | 0.74 | CTSA (0.39) | CTSAACHEALDH1A1KDM4EPOLB | |
| SCHEMBL3693476 | 0.73 | CTSA (0.32) | CTSAACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110461157-B | Herbicidal mixtures | 拜耳公司 | 2021-11-02 | — | — | CN | claimed |
| EP-0678096-A1 | SYNTHESIS OF DIMMER BLOCKS AND THEIR USE IN ASSEMBLING OLIGONUCLEOTIDES. | HYBRIDON INC (US) | 1995-10-25 | — | — | EP | claimed |
| WO-1994015946-A1 | SYNTHESIS OF DIMMER BLOCKS AND THEIR USE IN ASSEMBLING OLIGONUCLEOTIDES | HYBRIDON, INC. (US) | 1994-07-21 | — | — | WO | claimed |
| EP-4720050-A1 | PROCESS OF PREPARING HIV CAPSID INHIBITOR | GILEAD SCIENCES, INC. (US) | 2026-04-08 | — | — | EP | disclosed |
| WO-2024249672-A1 | PROCESS OF PREPARING HIV CAPSID INHIBITOR | GILEAD SCIENCES, INC. (US) | 2024-12-05 | — | — | WO | disclosed |
| US-20240018110-A1 | RADIOLABELED COMPOUNDS TARGETING THE PROSTATE-SPECIFIC MEMBRANE ANTIGEN | ALPHA-9 ONCOLOGY INC. (CA) | 2024-01-18 | — | — | US | disclosed |
| US-20240018110-A1 | RADIOLABELED COMPOUNDS TARGETING THE PROSTATE-SPECIFIC MEMBRANE ANTIGEN | ALPHA-9 ONCOLOGY INC. (CA) | 2024-01-18 | — | — | US | disclosed |
| US-20230114807-A1 | RADIOLABELED COMPOUNDS TARGETING THE PROSTATE-SPECIFIC MEMBRANE ANTIGEN | PROVINCIAL HEALTH SERVICES AUTHORITY (CA) | 2023-04-13 | — | — | US | disclosed |
| CN-110325543-B | Cyclic dinucleotides as STING (stimulator of interferon genes) agonists | 武田药品工业株式会社 | 2023-03-31 | — | — | CN | disclosed |
| WO-2022126275-A1 | RADIOLABELED COMPOUNDS TARGETING THE PROSTATE-SPECIFIC MEMBRANE ANTIGEN | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2022-06-23 | — | — | WO | disclosed |
| US-20210338851-A1 | RADIOLABELED COMPOUNDS TARGETING THE PROSTATE-SPECIFIC MEMBRANE ANTIGEN | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2021-11-04 | — | — | US | disclosed |
| US-5744465-A | Method of inhibiting a β-lactamase enzyme by administering novel 2-thiosubstituted carbapenems | AMERICAN CYANAMID COMPANY (US) | 1998-04-28 | — | — | US | disclosed |
| US-5623081-A | USING BENZYLOXYACETALDEHYDE DIMETHYL ETHER, HALOGENATED 1-PHENYLMETHOXY-4-PENTEN-2-OL; CYCLIZATION | LIN YANG-I (US) | 1997-04-22 | — | — | US | disclosed |
| US-5602118-A | A 2-((2-SUBSTITUTED ALKYL)FUR-3-YL)-THIO-),3-CARBOXY-2-CARBOPENEM DERIVATIVES; EFFECTIVE AGAINST BETA-LACTAM ANTIBIOTIC-RESISTANT BACTERIA | AMERICAN CYANAMID COMPANY (US) | 1997-02-11 | — | — | US | disclosed |
| CN-1104214-A | Novel 2-thiocarbpenems | AMERICAN CRANAMID COMPANY (US) | 1995-06-28 | — | — | CN | disclosed |
| EP-0444119-B1 | PROCESS FOR PRODUCING cDNA | DYNAL AS (NO) | 1995-05-17 | — | — | EP | disclosed |
| EP-0444119-A1 | PROCESS FOR PRODUCING cDNA. | HOLMES MICHAEL JOHN (GB) | 1991-09-04 | — | — | EP | disclosed |
| US-4975425-A | COMPOSITION FORMED FROM ALCOHOL, A MODIFIED COCODIETHANOLAMIDE AND WATER; RAPID ABSORPTION | MOBAY CORPORATION (US) | 1990-12-04 | — | — | US | disclosed |
| WO-1990006044-A2 | PROCESS FOR PRODUCING cDNA | DYNAL AS (NO) | 1990-06-14 | — | — | WO | disclosed |
| US-4059532-A | CELLULOSE | CIBA-GEIGY CORPORATION (US) | 1977-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210338851-A1 | RADIOLABELED COMPOUNDS TARGETING THE PROSTATE-SPECIFIC MEMBRANE ANTIGEN | FOLH1, KLK3, PSMA3 | CTSA 2046/4885ACHE 3501/4885ALDH1A1 2773/4885 |
| US-20240018110-A1 | RADIOLABELED COMPOUNDS TARGETING THE PROSTATE-SPECIFIC MEMBRANE ANTIGEN | KLK3, FOLH1, TMEM14C | CTSA 1275/4885ACHE 4425/4885ALDH1A1 2048/4885 |
| US-20230114807-A1 | RADIOLABELED COMPOUNDS TARGETING THE PROSTATE-SPECIFIC MEMBRANE ANTIGEN | FOLH1, KLK3, PSMA3 | CTSA 2046/4885ACHE 3501/4885ALDH1A1 2773/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.